Feiba NF

FEIBA NF (Anti-Inhibitor Coagulant Complex) is indicated for the control of spontaneous bleeding episodes or to cover surgical interventions in hemophilia A and hemophilia B patients with inhibitors.

Clinical experience suggests that patients with a Factor VIII inhibitor titer of less than 5 B.U. may be successfully treated with Antihemophilic Factor. Patients with titers ranging between 5 and 10 B.U. may either be treated with Antihemophilic Factor or FEIBA NF. Cases with Page 5 Factor VIII inhibitor titers greater than 10 B.U. have generally been refractory to treatment with Antihemophilic Factor.

For indications, dosing and other information, please refer to the prescribing information.

Feiba NF ‐ Baxalta

Size:
500 iu vial
NDC #:
64193-0423-02
Download:
PI
Size:
1000 iu vial
NDC #:
64193-0424-02
Download:
PI
Size:
2500 iu vial
NDC #:
64193-0425-02
Download:
PI